PrestoDoctor Announces Spring Savings for Patients
PrestoDoctor, a subsidiary of Dogecoin Cash, Inc. (OTCQB: CBDS), is thrilled to introduce a special promotion this April, providing a remarkable 42% discount on medical cannabis evaluations and renewals. This initiative is aimed at making medical cannabis more accessible to a broader audience.
Empowering Patients with Affordable Care
The promotion extends to both new patients and those returning for evaluations, utilizing PrestoDoctor's secure telemedicine platform. Celebrated annually on April 20, this discount aligns with the cultural recognition of cannabis and stands as a testament to the values that PrestoDoctor embodies: affordability, accessibility, and a commitment to patient wellness.
Community-Centric Approach
Rob Tankson, the COO of PrestoDoctor, emphasized, "This promotion is our way of giving back to the community that supports us all year long. We're committed to reducing barriers to accessing essential wellness resources through more economical options for our patients."
Convenient Process for Evaluations
Going through the evaluation process with PrestoDoctor is straightforward. Patients can easily sign up, choose a convenient appointment time, and participate in a video consultation with one of their licensed physicians. Following the evaluation, patients receive a digital recommendation instantly, with the official document mailed to them shortly thereafter.
About PrestoDoctor and Its Services
Recognized as the leading online platform for medical marijuana evaluations, PrestoDoctor has gained the trust of thousands of patients. This service offers unique, personalized treatment plans post-evaluation, administered by highly skilled professionals. Established in 2015, PrestoDoctor operates across multiple states where medical marijuana is legal, including California, Missouri, New York, and others, maintaining a high standard of service and care that has garnered over 20,000 five-star reviews.
Exploring Opportunities in Cannabis and Blockchain
Dogecoin Cash, Inc. preserves a pioneering spirit, engaging actively in both the cannabis and blockchain sectors. With innovative products like the first patented cannabis strain, Ecuadorian Sativa aka “CTA”, and a patented lozenge for hypertension treatment, CBDS is at the forefront of cannabis product development. The company is also exploring blockchain solutions, aiming for increased transparency and security within the cannabis supply chain.
Strategic Goals and Innovations
Dogecoin Cash, Inc. is committed to expanding its reach through strategic partnerships and innovative product offerings. The company seeks to navigate compliance while embracing new technologies to foster growth and enhance market presence in both cannabis and digital asset landscapes.
Stay Updated with Dogecoin Cash, Inc.
As the landscape for cannabis and blockchain continues to evolve, Dogecoin Cash, Inc. remains focused on its long-term strategic vision. Interested parties can follow the company for the latest updates and detailed information on their endeavors through their official site.
Frequently Asked Questions
What is the current promotion offered by PrestoDoctor?
PrestoDoctor is offering a 42% discount on medical cannabis evaluations and renewals throughout April.
Who can take advantage of this promotion?
This offer is open to both new patients and returning users in eligible states.
How does the evaluation process work with PrestoDoctor?
Patients can sign up online, schedule an appointment, and have a video consultation with a licensed physician who will provide a digital recommendation.
In which states does PrestoDoctor operate?
PrestoDoctor provides services in states with legalized medical marijuana, including California, New York, and more.
How does Dogecoin Cash, Inc. relate to the cannabis and blockchain industries?
Dogecoin Cash, Inc. actively engages in cannabis product development and blockchain technology to enhance service offerings and explore new market opportunities.
